{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:26:18Z","timestamp":1785432378725,"version":"3.56.0"},"reference-count":42,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI063517"],"award-info":[{"award-number":["R01AI063517"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI072219"],"award-info":[{"award-number":["R01AI072219"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health: Fogarty International Center","award":["D43 TW010319"],"award-info":[{"award-number":["D43 TW010319"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["mBio"],"published-print":{"date-parts":[[2025,8,13]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Tuberculosis (TB) continues to pose a global public health threat, exacerbated by rising drug-resistant strains of\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      (Mtb). DacB1, a D,D-carboxypeptidase critical in Mtb peptidoglycan biosynthesis, is a promising target for \u03b2-lactam antibiotics (BLs), which remain underutilized in TB treatment. Dual BL therapy may enhance efficacy by inactivating multiple targets within the peptidoglyan synthesis pathway. Minimum inhibitory concentrations (MICs) for \u03b2-lactams and \u03b2-lactamase inhibitors against Mtb H37Ra, H37Rv, and clinical isolates showed that imipenem, meropenem, or tebipenem MICs were reduced when combined with amoxicillin or ceftriaxone or \u03b2-lactamase inhibitors such as clavulanate or durlobactam. Timed electrospray ionization mass spectrometry (ESI-MS) captured acyl-enzyme adducts between DacB1 and BLs, revealing binding interactions with carbapenems (imipenem, meropenem, and tebipenem) but not most penicillins or cephalosporins except cloxacillin and cefoxitin. Differential scanning fluorimetry (DSF) combined with circular dichroism (CD) confirmed physical and structural changes in DacB1 upon BL binding despite no alteration in melting temperature. Carbapenem-DacB1 interactions were notably faster with imipenem, likely due to reduced steric hindrance compared to meropenem and tebipenem. Molecular modeling revealed conserved penicillin-binding protein motifs within the active site of DacB1: S\n                      <jats:sub>121<\/jats:sub>\n                      XXK124, S176XN178, and K282TG284 (PDB ID # 4PPR). Building on this, molecular docking suggested favorable interactions between these motifs and the carbapenems: the carbapenem carbonyl group aids in positioning within DacB1\u2019s oxyanion hole, ready for acylation, while hydrophobic interactions with the cyclic R2 side chains and C1 methyl groups in meropenem and tebipenem contribute to steric hindrance hence slow acyl-enzyme formation. These findings enhance our understanding of DacB1 inhibition and suggest that carbapenems, particularly in combination therapies, hold promise as effective TB treatments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>TB remains a significant public health threat, particularly due to the rising prevalence of drug-resistant Mtb strains. Current treatment options for drug-resistant TB are costly, toxic, and often ineffective, necessitating the exploration of alternative therapeutic strategies. This study is of critical importance as it investigates the potential of \u03b2-lactam antibiotics (BLs), a class historically considered ineffective against Mtb, for repurposing in TB treatment. By targeting DacB1, a key enzyme in Mtb peptidoglycan biosynthesis, this research provides new insights into the mechanism of \u03b2-lactam interactions and their potential to disrupt cell wall synthesis. The findings demonstrate that dual \u03b2-lactam therapy and \u03b2-lactam\/\u03b2-lactamase inhibitor combinations enhance antibiotic efficacy, suggesting a promising avenue for combating drug-resistant TB. Furthermore, structural and molecular analyses confirm that carbapenems, particularly imipenem, meropenem, and tebipenem, effectively bind to DacB1, paving the way for optimized treatment strategies. Given the challenges in developing new TB drugs, repurposing \u03b2-lactams offers a cost-effective and readily implementable solution to address antimicrobial resistance. This study contributes valuable knowledge that could accelerate the development of novel TB therapies, improve treatment success rates, and ultimately reduce TB-related mortality worldwide.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/mbio.01372-25","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:00:51Z","timestamp":1752152451000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["Exploring \u03b2-lactam interactions with DacB1: unraveling optimal therapies for combating drug-resistant\n                    <i>Mycobacterium tuberculosis<\/i>"],"prefix":"10.1128","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0137-6248","authenticated-orcid":false,"given":"Mary","family":"Nantongo","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/051fd9666","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Molecular Biology and Microbiology, Case Western Reserve University (CWRU)","place":["Cleveland, USA"]},{"id":[{"id":"https:\/\/ror.org\/01vrybr67","id-type":"ROR","asserted-by":"publisher"}],"name":"Research Service, Louis Stokes Veterans Affairs Medical Center","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5738-2976","authenticated-orcid":false,"given":"David C.","family":"Nguyen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01j7c0b24","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Infectious Diseases, Department of Pediatrics and Division of Infectious Diseases, Department of Internal Medicine, Rush University Medical Center","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2472-3264","authenticated-orcid":true,"given":"Eunjeong","family":"Shin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01vrybr67","id-type":"ROR","asserted-by":"publisher"}],"name":"Research Service, Louis Stokes Veterans Affairs Medical Center","place":["Cleveland, USA"]},{"name":"Department of Medicine, CWRU","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Bethel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01vrybr67","id-type":"ROR","asserted-by":"publisher"}],"name":"Research Service, Louis Stokes Veterans Affairs Medical Center","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena A.","family":"Taracila","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01vrybr67","id-type":"ROR","asserted-by":"publisher"}],"name":"Research Service, Louis Stokes Veterans Affairs Medical Center","place":["Cleveland, USA"]},{"name":"Department of Medicine, CWRU","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3272-7231","authenticated-orcid":true,"given":"Khalid M.","family":"Dousa","sequence":"additional","affiliation":[{"name":"Department of Medicine, CWRU","place":["Cleveland, USA"]},{"id":[{"id":"https:\/\/ror.org\/051fd9666","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical Service, Veterans Affairs Northeast Ohio Healthcare System (VANEOHS)","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine, CWRU","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Department of Medicine, CWRU","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian G.","family":"Kurz","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yale School of Medicine","place":["New Haven, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-131X","authenticated-orcid":true,"given":"Barry N.","family":"Kreiswirth","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00fgmrc59","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Discovery and Innovation","place":["Hackensack, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Henry","family":"Boom","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/051fd9666","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Molecular Biology and Microbiology, Case Western Reserve University (CWRU)","place":["Cleveland, USA"]},{"name":"Department of Medicine, CWRU","place":["Cleveland, USA"]},{"id":[{"id":"https:\/\/ror.org\/01gc0wp38","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Holland","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Clinical Immunology and Microbiology, National Institutes of Health, National Institute of Allergy and Infectious Diseases","place":["Bethesda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5120-962X","authenticated-orcid":true,"given":"Eric J.","family":"Rubin","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3299-894X","authenticated-orcid":true,"given":"Robert A.","family":"Bonomo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/051fd9666","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Molecular Biology and Microbiology, Case Western Reserve University (CWRU)","place":["Cleveland, USA"]},{"name":"Department of Medicine, CWRU","place":["Cleveland, USA"]},{"id":[{"id":"https:\/\/ror.org\/051fd9666","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical Service, Veterans Affairs Northeast Ohio Healthcare System (VANEOHS)","place":["Cleveland, USA"]},{"name":"Departments of Biochemistry, Pharmacology, and Proteomics and Bioinformatics, CWRU; Cleveland Geriatrics Research Education and Clinical Center (GRECC), VANEOHS; CWRU Cleveland VAMC Center for Antibiotic Resistance and Epidemiology (Case VA CARES)","place":["Cleveland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","unstructured":"WHO. 2024. Global tuberculosis report 2024. Geneva World Health Organization"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09079-5"},{"key":"e_1_3_1_4_2","unstructured":"CDC. 2019. Antibiotic resistance threats in the United States 2019. Atlanta GA U.S. Department of Health and Human Services"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11131946"},{"key":"e_1_3_1_6_2","unstructured":"2022. WHO consolidated guidelines on tuberculosis module 4: treatment \u2013 drug-resistant tuberculosis treatment 2022 Update. World Health Organization Geneva."},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30308-3"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2020.06.009"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2020.06.001"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.985871"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2014.94"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.27629-0"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00609-24"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab535"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01781-23"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1167498"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3579832"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx152"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2007.00094.x"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.19469"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41001-x"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2008.04.006"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.71947"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00819-16"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1899052"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020983"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2012.08199.x"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116249"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.4c00119"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm020503a"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.1c00185"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01027-12"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2237"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00424-22"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.612-618.2005"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1124"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0134(20010501)43:2<113::aid-prot1023>3.0.co;2-t"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci6004299"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/0471140864.ps2809s79"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mie.2015.08.027"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.674"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.321"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1021\/ac303244g"}],"container-title":["mBio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mbio.01372-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mbio.01372-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T13:03:27Z","timestamp":1755090207000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/mbio.01372-25"}},"subtitle":[],"editor":[{"given":"Vanessa","family":"Sperandio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Michael U.","family":"Shiloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,13]]}},"alternative-id":["10.1128\/mbio.01372-25"],"URL":"https:\/\/doi.org\/10.1128\/mbio.01372-25","relation":{},"ISSN":["2150-7511"],"issn-type":[{"value":"2150-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"2025-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01372-25"}}